Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

<< Previous

Bullboard Posts

Next >>

Post by WakeUPPon May 17, 2021 10:41am

135 Views

Post# 33213720

lex!!!!!!!!!

what is happenning

DOWN, again

where is the $20, $100 +++ you SAiD it would hit last week??????????

where is the short squeeze???????????

sure looks like just another biotec that released a meaningless test on 10 rats to me'

say it aint so lex

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project